[
    [
        {
            "time": "2018-11-23",
            "original_text": "Health Care Sector Update for 11/23/2018: ESRX,CI,NVO,IPCI",
            "features": {
                "keywords": [
                    "Health",
                    "Care",
                    "Sector",
                    "Update",
                    "ESRX",
                    "CI",
                    "NVO",
                    "IPCI"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Health Care Sector Update for 11/23/2018: ESRX,CI,NVO,IPCI",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-11-23",
            "original_text": "Novo Nordisk Announces Results From Last Global Phase 3a Trial, PIONEER 6",
            "features": {
                "keywords": [
                    "Novo",
                    "Nordisk",
                    "Announces",
                    "Results",
                    "Global",
                    "Phase",
                    "3a",
                    "Trial",
                    "PIONEER",
                    "6"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Nordisk Announces Results From Last Global Phase 3a Trial, PIONEER 6",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]